Granutec Acquisition Gives Leiner Strong Private Label OTC Position
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' acquisition of Granutec and Stanley Pharmaceuticals for approximately $60.1 mil., announced as completed Dec. 21, makes Leiner the leading supplier of private label "self-care products" in the U.S., the company said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning